389 related articles for article (PubMed ID: 30187289)
1. Medication-Induced Xerostomia and Hyposalivation in the Elderly: Culprits, Complications, and Management.
Barbe AG
Drugs Aging; 2018 Oct; 35(10):877-885. PubMed ID: 30187289
[TBL] [Abstract][Full Text] [Related]
2. Buccal drug delivery technologies for patient-centred treatment of radiation-induced xerostomia (dry mouth).
Malallah OS; Garcia CMA; Proctor GB; Forbes B; Royall PG
Int J Pharm; 2018 Apr; 541(1-2):157-166. PubMed ID: 29425763
[TBL] [Abstract][Full Text] [Related]
3. Salivary hypofunction and xerostomia: diagnosis and treatment.
Atkinson JC; Grisius M; Massey W
Dent Clin North Am; 2005 Apr; 49(2):309-26. PubMed ID: 15755407
[TBL] [Abstract][Full Text] [Related]
4. Medication-induced hyposalivation: etiology, diagnosis, and treatment.
Moore PA; Guggenheimer J
Compend Contin Educ Dent; 2008; 29(1):50-5. PubMed ID: 18361341
[TBL] [Abstract][Full Text] [Related]
5. Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations.
von Bültzingslöwen I; Sollecito TP; Fox PC; Daniels T; Jonsson R; Lockhart PB; Wray D; Brennan MT; Carrozzo M; Gandera B; Fujibayashi T; Navazesh M; Rhodus NL; Schiødt M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103 Suppl():S57.e1-15. PubMed ID: 17379156
[TBL] [Abstract][Full Text] [Related]
6. Salivary hypofunction: An update on therapeutic strategies.
Salum FG; Medella-Junior FAC; Figueiredo MAZ; Cherubini K
Gerodontology; 2018 Dec; 35(4):305-316. PubMed ID: 29956369
[TBL] [Abstract][Full Text] [Related]
7. Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies.
Nieuw Amerongen AV; Veerman EC
Support Care Cancer; 2003 Apr; 11(4):226-31. PubMed ID: 12673460
[TBL] [Abstract][Full Text] [Related]
8. Hyposalivation and Xerostomia and Burning Mouth Syndrome: Medical Management.
Thakkar JP; Lane CJ
Oral Maxillofac Surg Clin North Am; 2022 Feb; 34(1):135-146. PubMed ID: 34598858
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the use of sialogogues in the clinical management of patients with xerostomia.
Chainani-Wu N; Gorsky M; Mayer P; Bostrom A; Epstein JB; Silverman S
Spec Care Dentist; 2006; 26(4):164-70. PubMed ID: 16927740
[TBL] [Abstract][Full Text] [Related]
10. Managing xerostomia and salivary gland hypofunction: executive summary of a report from the American Dental Association Council on Scientific Affairs.
Plemons JM; Al-Hashimi I; Marek CL;
J Am Dent Assoc; 2014 Aug; 145(8):867-73. PubMed ID: 25082939
[TBL] [Abstract][Full Text] [Related]
11. Safety and effectiveness of topical dry mouth products containing olive oil, betaine, and xylitol in reducing xerostomia for polypharmacy-induced dry mouth.
Ship JA; McCutcheon JA; Spivakovsky S; Kerr AR
J Oral Rehabil; 2007 Oct; 34(10):724-32. PubMed ID: 17824884
[TBL] [Abstract][Full Text] [Related]
12. Comparing the effectiveness and adverse effects of pilocarpine and cevimeline in patients with hyposalivation.
Farag AM; Holliday C; Cimmino J; Roomian T; Papas A
Oral Dis; 2019 Nov; 25(8):1937-1944. PubMed ID: 31520497
[TBL] [Abstract][Full Text] [Related]
13. Xerostomia in geriatric patients: a burgeoning global concern.
Anil S; Vellappally S; Hashem M; Preethanath RS; Patil S; Samaranayake LP
J Investig Clin Dent; 2016 Feb; 7(1):5-12. PubMed ID: 25175324
[TBL] [Abstract][Full Text] [Related]
14. Xerostomia: prevalence and pharmacotherapy. With special reference to beta-adrenoceptor antagonists.
Nederfors T
Swed Dent J Suppl; 1996; 116():1-70. PubMed ID: 8813731
[TBL] [Abstract][Full Text] [Related]
15. Xerostomia: causes and treatment.
Wick JY
Consult Pharm; 2007 Dec; 22(12):985-92. PubMed ID: 18198958
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of cevimeline hydrochloride in the treatment of xerostomia in Sjögren's syndrome in southern Chinese patients: a randomised double-blind, placebo-controlled crossover study.
Leung KC; McMillan AS; Wong MC; Leung WK; Mok MY; Lau CS
Clin Rheumatol; 2008 Apr; 27(4):429-36. PubMed ID: 17899308
[TBL] [Abstract][Full Text] [Related]
17. Prevention and treatment options for medication-induced xerostomia.
Quilici D; Zech KN
Gen Dent; 2019; 67(4):52-57. PubMed ID: 31355765
[TBL] [Abstract][Full Text] [Related]
18. Effects of pilocarpine hydrochloride and cevimeline on submandibular/sublingual salivation in rat xerostomia model produced by X-ray irradiation.
Omori Y; Asari T; Maruyama K; Kusama H; Kojima M; Shibata N
Arzneimittelforschung; 2003; 53(5):342-50. PubMed ID: 12854361
[TBL] [Abstract][Full Text] [Related]
19. [Prognosis and treatment of dry mouth. Systematic review].
López-López J; Jané Salas E; Chimenos Küstner E
Med Clin (Barc); 2014 Feb; 142(3):119-24. PubMed ID: 23726507
[TBL] [Abstract][Full Text] [Related]
20. Sedative load and salivary secretion and xerostomia in community-dwelling older people.
Tiisanoja A; Syrjälä AM; Komulainen K; Hartikainen S; Taipale H; Knuuttila M; Ylöstalo P
Gerodontology; 2016 Jun; 33(2):177-84. PubMed ID: 24766552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
